CAMURUS AB CAMURUS ORD SHS (0RD1.L) Financials

0RD1.L Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 1.8 billion 353.4 million
2023-06-30 1.8 billion 391.7 million
2023-03-31 1.3 billion 288.6 million

0RD1.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 ? ?
2023-09-30 484.3 million 17.8 million
2023-06-30 62.4 million 19.8 million
2023-03-31 23.3 million 5.5 million

0RD1.L Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -15.2 million
2023-09-30 86.4 million
2023-06-30 301.4 million
2023-03-31 58.8 million

0RD1.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 1.2 billion - -
2023-06-30 654.1 million - -
2023-03-31 585.8 million - -

0RD1.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 ?
2023-09-30 57.5 million
2023-06-30 57.5 million
2023-03-31 57.5 million

0RD1.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 1.4 million 147.7 million 10.4 million 94.4 million
2023-06-30 4.5 million 160.6 million 12.1 million 94.0 million
2023-03-31 928000 99.3 million 9.3 million 75.6 million

0RD1.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - -
2023-09-30 384.0 million 32.0 million
2023-06-30 674.3 million 29.0 million
2023-03-31 284.0 million 28.8 million

0RD1.L

Price: SEK554.50

52 week price:
197.70
596.00

Earnings Per Share: -1.27 SEK

P/E Ratio: -355.10

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 234.4 million

Links: